Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Nussenzweig: Development of optimized broadly neutralizing antibodies for HIV-1 prevention |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2016-05-27 |
| Study Made Public: | 2019-03-15 |
Title
Evaluation of the neutralizing activity of Fc-modified and bispecific bNAbs
Description
CAVD 569 is an immunogenicity study of Fc-modified and bispecific broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.